Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 509 (RNA5SP509) is an rRNA pseudogene derived from the 5S ribosomal RNA gene family, identifiable within the genome by sequence similarity but not encoding a functional RNA molecule. Pseudogenes are divided into several types (unitary, unprocessed/duplicated, processed); rRNA pseudogenes like RNA5SP509 typically result from mutations or errors in DNA duplication or retrotransposition that render them transcriptionally or functionally silent. While 5S ribosomal RNA molecules play key roles in ribosome assembly and protein synthesis, pseudogene relatives such as RNA5SP509 are generally nonfunctional. In rare circumstances, some pseudogenes are transcribed and may modulate the expression of other genes through regulatory networks, but there is no evidence for specific biological roles or clinical relevance of RNA5SP509 itself. It is not a valid therapeutic target and should not be regarded as a receptor or active biomolecule[2][4][1][6].
None (no drugs act upon it)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 509 (RNA5SP509).